Michael F M James1, Anthony M Roche. 1. Department of Anaesthesia, Groote Schuur Hospital and University of Cape Town, Western Cape, South Africa. james@cormack.uct.ac.za
Abstract
OBJECTIVES: To establish the threshold value for calcium at which coagulation commenced and to investigate the range over which changes in ionized calcium influenced coagulation. DESIGN: Controlled, nonblinded, in vitro observational study. SETTING: The study was conducted in a university-based laboratory. PARTICIPANTS: Blood was obtained from healthy volunteers. INTERVENTIONS: One hundred samples of citrated blood were recalcified using varying quantities of 10% calcium chloride solution. Heparinized samples from the recalcified blood were obtained for measurement of ionized calcium concentration (Ca(2+)). MEASUREMENTS AND RESULTS: Coagulation of the recalcified samples was analyzed using thrombelastography. The ionized calcium concentration in recalcified blood was measured using a calcium electrode in a blood gas analyzer. No sample with a Ca(2+) < 0.33 mmol/L showed any clot formation. Normal coagulation measures were obtained in almost all samples in which the Ca(2+) was >0.56 mmol/L. Final clot strength appeared to be independent of Ca(2+) once the threshold value of 0.33 mmol/L was exceeded. CONCLUSIONS: Ca(2+) of <0.33 mmol/L is necessary to prevent coagulation. Ca(2+) > 0.56 is unlikely to be the cause of coagulation abnormalities during surgical procedures in which calcium metabolism is deranged. Between these values, Ca(2+) may exert an effect on the rate of clot formation, but final clot strength should be unaffected.
OBJECTIVES: To establish the threshold value for calcium at which coagulation commenced and to investigate the range over which changes in ionizedcalcium influenced coagulation. DESIGN: Controlled, nonblinded, in vitro observational study. SETTING: The study was conducted in a university-based laboratory. PARTICIPANTS: Blood was obtained from healthy volunteers. INTERVENTIONS: One hundred samples of citrated blood were recalcified using varying quantities of 10% calcium chloride solution. Heparinized samples from the recalcified blood were obtained for measurement of ionizedcalcium concentration (Ca(2+)). MEASUREMENTS AND RESULTS: Coagulation of the recalcified samples was analyzed using thrombelastography. The ionizedcalcium concentration in recalcified blood was measured using a calcium electrode in a blood gas analyzer. No sample with a Ca(2+) < 0.33 mmol/L showed any clot formation. Normal coagulation measures were obtained in almost all samples in which the Ca(2+) was >0.56 mmol/L. Final clot strength appeared to be independent of Ca(2+) once the threshold value of 0.33 mmol/L was exceeded. CONCLUSIONS:Ca(2+) of <0.33 mmol/L is necessary to prevent coagulation. Ca(2+) > 0.56 is unlikely to be the cause of coagulation abnormalities during surgical procedures in which calcium metabolism is deranged. Between these values, Ca(2+) may exert an effect on the rate of clot formation, but final clot strength should be unaffected.
Authors: Marc Blondon; Rebecca J Rodabough; Nicole Budrys; Karen C Johnson; Jeffrey S Berger; James M Shikany; Azad Raiesdana; Susan R Heckbert; JoAnn E Manson; Andrea Z LaCroix; David Siscovick; Bryan Kestenbaum; Nicholas L Smith; Ian H de Boer Journal: Thromb Haemost Date: 2015-02-12 Impact factor: 5.249
Authors: Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Philip F Stahel; Jean-Louis Vincent; Donat R Spahn Journal: Crit Care Date: 2010-04-06 Impact factor: 9.097
Authors: Zachary A Matthay; Alexander T Fields; Brenda Nunez-Garcia; Maya H Patel; Mitchell J Cohen; Rachael A Callcut; Lucy Z Kornblith Journal: J Trauma Acute Care Surg Date: 2020-11 Impact factor: 3.313
Authors: Rolf Rossaint; Bertil Bouillon; Vladimir Cerny; Timothy J Coats; Jacques Duranteau; Enrique Fernández-Mondéjar; Daniela Filipescu; Beverley J Hunt; Radko Komadina; Giuseppe Nardi; Edmund A M Neugebauer; Yves Ozier; Louis Riddez; Arthur Schultz; Jean-Louis Vincent; Donat R Spahn Journal: Crit Care Date: 2016-04-12 Impact factor: 9.097